Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa

International Journal of Epidemiology

Volumn 40, Issue 4, 2011, Pages 922-930

  Karim, Quarraisha Abdool ^a,b   Kharsany, Ayesha B M ^a   Frohlich, Janet A ^a   Mashego, May ^a   Mlotshwa, Mukelisiwe ^a   Madlala, Bernadette T ^a   Ntombela, Fanelesibonge ^a   Abdool Karim, Salim S ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Columbia University ^*  (United States)

Author keywords

HIV incidence; HIV prevalence; South Africa; Young women

Indexed keywords

DEMOGRAPHIC SURVEY; DISEASE INCIDENCE; DISEASE PREVALENCE; EPIDEMIC; FAMILY PLANNING; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; QUESTIONNAIRE SURVEY; RURAL-URBAN COMPARISON; SURVIVAL; WOMENS HEALTH;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MORBIDITY; PATIENT COUNSELING; PELVIC EXAMINATION; PREGNANCY RATE; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SCREENING TEST; SEXUAL BEHAVIOR; SOUTH AFRICA; STRUCTURED QUESTIONNAIRE; URBAN AREA;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; RURAL POPULATION; SEXUAL BEHAVIOR; SOUTH AFRICA; URBAN POPULATION; WOMEN'S HEALTH; YOUNG ADULT;

KWAZULU-NATAL; SOUTH AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80051929539     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq176     Document Type: Article

References (41)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update. Geneva, Switzerland 2009. http://data.unaids.org/pub/Report/2009/2009_epidemic_update_en.pdf (25 February 2010, date last accessed).
2. Shisana O, Rehle T, Simbayi LC et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey 2008: A Turning Tide Among Teenagers? Cape Town: HSRC Press, 2009.
3. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 2009;374: 921-33.
4. Pettifor AE, Rees HV, Kleinschmidt I et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005;19: 1525-34.
5. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). Practical Guidelines for Intensifying HIV Prevention: Towards Universal Access. Geneva, Switzerland. ISBN 978 92 9173 557 0 (NLM classification: WC 503.2), 2007.
6. Department of Health. National Antenatal Sentinel HIV and Syphilis Prevalence Survey, 2008, South Africa. Pretoria: National Department of Health, 2009.
7. Stats SA. Mid-year Population Estimates; Statistical Release PO 302. http://www.statssa.gov.za, Pretoria: Statistics South Africa, 2009. (25 February 2010, date last accessed).
8. Ghys PD, Kufa E, George MV. Measuring trends in prevalence and incidence of HIV infection in countries with generalised epidemics. Sex Transm Infect 2006; 82(Suppl 1):i52-56.
9. Adam MA, Johnson LF. Estimation of adult antiretroviral treatment coverage in South Africa. S Afr Med J 2009;99: 661-67.
10. Wilson D, Halperin DT. "Know your epidemic, know your response": a useful approach, if we get it right. Lancet 2008;372:423-26.
11. Collins C, Coates TJ, Curran J. Moving beyond the alphabet soup of HIV prevention. AIDS 2008; 22(Suppl 2):S5-8.
12. UNAIDS/WHO. Trends in HIV Incidence and Prevalence: Natural Course of the Epidemic or Results of Behavioural Change? Geneva, Switzerland: UNAIDS/WHO, 1999.
13. Bradshaw D, Nannan N, Groenewald P et al. Provincial mortality in South Africa, 2000-priority-setting for now and a benchmark for the future. S Afr Med J 2005;95: 496-503.
14. Mashego M, Johnson D, Frohlich J, Carrara H, Karim QA. High AIDS-related mortality among young women in rural KwaZulu-Natal. S Afr Med J 2007;97:587-92.
15. Hallett TB, Zaba B, Todd J et al. Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 2008;5:e80.
16. Abdool Karim S. HIV incidence estimates are key to understanding the changing HIV epidemic in South Africa. S Afr Med J 2007;97:190.
17. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. National HIV incidence measures-new insights into the South African epidemic. S Afr Med J 2007;97:194-99.
18. MacQueen KM, Karim QA. Practice brief: adolescents and HIV clinical trials: ethics, culture, and context. J Assoc Nurses AIDS Care 2007;18:78-82.
19. Department of Health. Guidelines for Good Practice in the Conduct of Clinical Trials with Human Participants in South Africa. Pretoria, South Africa: Department of Health, 2006.
20. South Africa Department of Health. Standard Treatment Guidelines and Essential Drugs List, 2003 Edition. Pretoria, South Africa: The National Department of Health, 2003.
21. van Loggerenberg F, Mlisana K, Williamson C et al. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One 2008;3:e1954.
22. Ramjee G, Kapiga S, Weiss S et al. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study. J Acquir Immune Defic Syndr 2008;47:93-100.
23. Kapina M, Reid C, Roman K et al. HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sex Transm Dis 2009;36: 129-33.
24. Kumwenda NI, Kumwenda J, Kafulafula G et al. HIV-1 incidence among women of reproductive age in Malawi. Int J STD AIDS 2008;19:339-41.
25. Kumwenda N, Hoffman I, Chirenje M et al. HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis 2006;33:646-51.
26. World Health Organization and Joint United Nations. Guidance on Provider-initiated HIV Testing and Counselling in Health Facilities. Geneva, Switzerland: World Health Organization and Joint United Nations, 2007.
27. Gouws E. HIV incidence rates in South Africa. In: Abdool Karim SS, Abdool Karim Q (eds). HIV/AIDS in South Africa. 2nd edn. New York: Cambridge University Press, 2010, pp. 74-84.
28. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008;372:669-84.
29. Fathalla MF, Sinding SW, Rosenfield A, Fathalla MM. Sexual and reproductive health for all: a call for action. Lancet 2006;368:2095-100.
30. Bearinger LH, Sieving RE, Ferguson J, Sharma V. Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential. Lancet 2007;369:1220-31.
31. Chopra M, Lawn JE, Sanders D et al. Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet 2009;374:1023-31.
32. Padian NS, Buve A, Balkus J, Serwadda D, Cates W Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet 2008;372: 585-99.
33. Wilcher R, Petruney T, Reynolds HW, Cates W. From effectiveness to impact: contraception as an HIV prevention intervention. Sex Transm Infect 2008;84(Suppl 2): ii54-60.
34. Wilcher R, Cates W Jr, Gregson S. Family planning and HIV: strange bedfellows no longer. AIDS 2009; 23(Suppl 1):S1-6.
35. IOM (Institute of Medicine). Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press, 2008.
36. Gappoo S, Montgomery ET, Gerdts C et al. Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemp Clin Trials 2009;30:411-18.
37. Plummer ML, Ross DA, Wight D et al. A bit more truthful: the validity of adolescent sexual behaviour data collected in rural northern Tanzania using five methods. Sex Transm Infect 2004;80(Suppl 2): ii49-56.
38. Raymond EG, Taylor D, Cates W Jr et al. Pregnancy in effectiveness trials of HIV prevention agents. Sex Transm Dis 2007;34:1035-39.
39. Peterson L, Nanda K, Opoku BK et al. SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One 2007;2:e1312.
40. MacQueen KM, Johnson L, Alleman P, Akumatey B, Lawoyin T, Nyiama T. Pregnancy prevention practices among women with multiple partners in an HIV prevention trial. J Acquir Immune Defic Syndr 2007;46: 32-38.
41. Feldblum PJ, Adeiga A, Bakare R et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One 2008;3:e1474.